It’s our immense pleasure to announce that we got
Troikaa Pharmaceuticals, a new feather in our portfolio, at Kas Medics,
Tanzania. We celebrated this glorious achievement with a cake cutting ceremony
at our office in Dar es salaam.
Troikaa is a company that focuses on high science
segments like Biosimilars, and pain management. They are well known for their Dynapar
Injection, a patented technology. This is just the start and soon we expect to have
other similar high science products from Troikaa in our portfolio, thus adding
great value to our Kas brand!
Troikaa Biosimilars have a Bevacizumab Injection, and
we Kas Medics are the only company, who have this molecule registered by the
Tanzania FDA, which is used for colon cancer, lung cancer, glioblastoma, and
renal cell carcinoma. The Troikaa Rituximab Injections are used to treat cancer
such as non- lymphoma chronic lymphocytic leukaemia. It helps to stop or
slow down the growth of cancer cells.
The Dynapar Injection with patented technology of
Aquatech process is virtually painless at the site of injection which leads to
less muscle damage and human sensitivity. It can be given Intra gluteal, Intra deltoid,
IV Infusion and IV bolus.
Leave a Reply